SUPN - Supernus Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6366
Avg. Estimate0.60.322.071.45
Low Estimate0.560.212.041.18
High Estimate0.730.382.11.87
Year Ago EPS0.480.342.052.07
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6366
Avg. Estimate111.53M89.64M399.21M407.73M
Low Estimate104.77M84.6M395M395M
High Estimate130M94.82M403M426.81M
Year Ago Sales115.93MN/A408.9M399.21M
Sales Growth (year/est)-3.80%N/A-2.40%2.10%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.0.270.470.580.6
EPS Actual0.480.340.610.54
Difference0.21-0.130.03-0.06
Surprise %77.80%-27.70%5.20%-10.00%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate0.60.322.071.45
7 Days Ago0.60.322.071.45
30 Days Ago0.60.292.061.42
60 Days Ago0.60.292.081.42
90 Days Ago0.650.232.191.98
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/A11
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesSUPNIndustrySectorS&P 500
Current Qtr.25.00%N/AN/A0.01
Next Qtr.-5.90%N/AN/A0.06
Current Year1.00%N/AN/A-0.02
Next Year-30.00%N/AN/A0.14
Next 5 Years (per annum)37.00%N/AN/A0.08
Past 5 Years (per annum)59.19%N/AN/AN/A